|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Kintara Therapeutics (NASDAQ: KTRA) through any online brokerage.
The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Aegis Capital on February 3, 2021. The analyst firm set a price target for 7.00 expecting KTRA to rise to within 12 months (a possible 268.42% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Kintara Therapeutics (NASDAQ: KTRA) is $1.9 last updated Thu Jun 17 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Kintara Therapeutics.
There is no upcoming split for Kintara Therapeutics.
Kintara Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.